This is a community-generated profile. If you would like to claim it, please .
Dynavax Technologies Funding
$225M
11 round
Dynavax Technologies is active in the following markets / industries: biotechnology and pharmaceuticals. The company has secured funding across 1 rounds, totaling in an amount of $225M. Their most recent funding was raised on March 6, 2025.
Funding Rounds
S
$225000000Investors of Dynavax Technologies
James C. Hansberger Jr.
Co-Founder
ePanacea
1999-2000
Senior Portfolio Management Director
Morgan Stanley
2001-2011
Co-founder, CO-CEO
UpSprout
2020-Present
Augie Kuo
VP Engineering/co-founder Seamless Microsystems